Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Management of diabetes and pancreatic cancer.

Flaherty AM.

Oncol Nurs Forum. 2012 Sep;39(5):440-3. doi: 10.1188/12.ONF.440-443. Review. No abstract available.

PMID:
22940508
2.

Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX.

Silvestris N, Brunetti AE, Russano M, Nardulli P.

Support Care Cancer. 2013 Nov;21(11):2955-6. doi: 10.1007/s00520-013-1944-y. Epub 2013 Aug 23. No abstract available.

PMID:
23975230
4.

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas.

Choi CW, Choi IK, Seo JH, Kim BS, Kim JS, Kim CD, Um SH, Kim JS, Kim YH.

Am J Clin Oncol. 2000 Aug;23(4):425-8.

PMID:
10955877
5.

[Clinical usefulness of oral aprepitant for alleviation of delayed nausea and vomiting induced by mFOLFOX6--report of a case].

Abe T, Hachiro Y, Kunimoto M.

Gan To Kagaku Ryoho. 2010 Dec;37(13):2933-5. Japanese.

PMID:
21160274
6.

A R0 resection case of initially unresectable metastatic pancreatic cancer downstaged by FOLFIRINOX therapy.

Sasaki T, Isayama H, Aoki T, Tanaka M, Hamada T, Nakai Y, Sakamoto Y, Hasegawa K, Morikawa T, Fukayama M, Kokudo N, Koike K.

Pancreas. 2014 Aug;43(6):972-4. doi: 10.1097/MPA.0000000000000139. No abstract available.

PMID:
25010709
7.

Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.

Kalofonos HP, Papakostas P, Makatsoris T, Papamichael D, Vourli G, Xanthakis I, Aravantinos G, Papadimitriou C, Pentheroudakis G, Varthalitis I, Samelis G, Syrigos KN, Xiros N, Stavropoulos M, Kosmidis P, Christodoulou C, Linardou H, Skondra M, Pectasides D, Economopoulos T, Fountzilas G.

Anticancer Res. 2010 Oct;30(10):4325-33.

PMID:
21036759
8.

Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.

Huguier M, Barrier A, Valinas R, Flahault A, Adloff M, Pezet D, Jaeck D, Millat B; French University Association for Surgical Research.

Hepatogastroenterology. 2001 May-Jun;48(39):875-8.

PMID:
11462946
9.

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.

Nauck MA, Duran S, Kim D, Johns D, Northrup J, Festa A, Brodows R, Trautmann M.

Diabetologia. 2007 Feb;50(2):259-67. Epub 2006 Dec 8.

PMID:
17160407
10.

Treatment of type 2 diabetes mellitus and the incretin system.

Whitehill D.

S D Med. 2007 May;60(5):197, 199. No abstract available.

PMID:
17694940
11.

Role of metformin in type II diabetes.

Epstein S.

Cleve Clin J Med. 1995 Sep-Oct;62(5):278-9. Review. No abstract available.

PMID:
7586481
13.

Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma.

Tinchon C, Hubmann E, Pichler A, Keil F, Pichler M, Rabl H, Uggowitzer M, Jilek K, Leitner G, Bauernhofer T.

Acta Oncol. 2013 Aug;52(6):1231-3. doi: 10.3109/0284186X.2013.771821. Epub 2013 Feb 27. No abstract available.

PMID:
23445338
14.

[Sequential treatment with insulin glargine and metformin, and exenatide in a patient with newly diagnosed type-2 diabetes].

Kress S.

Dtsch Med Wochenschr. 2010 May;135(18):907-10. doi: 10.1055/s-0030-1253676. Epub 2010 Apr 27. German.

PMID:
20425675
16.
17.

Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.

Gagnadoux F, Roiron C, Carrie E, Monnier-Cholley L, Lebeau B.

Am J Clin Oncol. 2002 Aug;25(4):388-90.

PMID:
12151971
18.

FOLFIRINOX in locally advanced pancreatic cancer: the starting point for questioning.

Levy A, Chargari C, Huguet F, Védrine L, Deutsch E.

Pancreas. 2012 Aug;41(6):973-4. doi: 10.1097/MPA.0b013e3182496e90. No abstract available.

PMID:
22781912
19.

Multi-institutional experience with FOLFIRINOX in pancreatic adenocarcinoma.

Peddi PF, Lubner S, McWilliams R, Tan BR, Picus J, Sorscher SM, Suresh R, Lockhart AC, Wang J, Menias C, Gao F, Linehan D, Wang-Gillam A.

JOP. 2012 Sep 10;13(5):497-501. doi: 10.6092/1590-8577/913.

20.

Severe hiccups during chemotherapy: corticosteroids the likely culprit.

Gilbar P, McPherson I.

J Oncol Pharm Pract. 2009 Dec;15(4):233-6. doi: 10.1177/1078155209102336. Epub .

PMID:
19276142
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk